Anterior pituitary hormones (Formulary: Endocrine)

Warning

TETRACOSACTIDE

Important: Therapy notes

Important: Formulation and dosage details

Formulation:

Injection 250 micrograms/1mL (s)

Dosage:

For assessment of adrenal response in the short synacthen test, by intravenous or intramuscular injection, 250 micrograms given at zero minutes.
Samples are taken for serum cortisol at zero and 30 minutes.

SOMATROPIN

Important: Therapy notes

  • Somatropin should be prescribed by brand name.

Important: Formulation and dosage details

Formulation:

Powder and solvent for solution for injection pre-filled disposable devices, 200 micrograms, 400 micrograms, 600 micrograms, 800 micrograms, 1mg, 1·2mg, 1·4mg, 1·6mg, 1·8mg, 2mg (Genotropin MiniQuick®) (s)

Important: Formulation and dosage details

Formulation:

Powder and solvent for solution for injection cartridges 5·3mg, 12mg (Genotropin®) (s)

Important: Formulation and dosage details

Formulation:

Solution for Injection Pre-Filled Pen 5mg/1·5ml, 10mg/1·5ml, 15mg/1·5ml (Norditropin Flex Pro®) (s)

Important: Formulation and dosage details

Formulation:

Solution for injection cartridges 6mg/1.03mL, 12mg/1.5mL, 20mg/2.5mL (Saizen®) (s)

Important: Formulation and dosage details

Formulation:

Solution for injection cartridges 5mg/1·5mL, 10mg/1·5mL, 15mg/1·5mL (Omnitrope Surepal®) (s)

SOMAPACITAN

Important: Therapy notes

  • Needles and a purple sharps bin need to be prescribed.

Important: Formulation and dosage details

Formulation:

Solution for injection in pre-filled pen (Restricted: Specialist recommendation only)

Dosage:

Indication as per SMC2629: For the replacement of endogenous growth hormone (GH) in children aged 3 years and above, and adolescents with growth failure due to growth hormone deficiency (paediatric GHD), and in adults with growth hormone deficiency (adult GHD).
SMC restriction: for children aged 3 years and above and adolescents with growth failure due to growth hormone deficiency (paediatric GHD). 

Editorial Information

Last reviewed: 26/02/2026

Next review date: 28/02/2029

Version: 1.1

Approved By: TAM subgroup of the ADTC

Document Id: F189